KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Biocryst Pharmaceuticals (BCRX) Return on Equity (2023 - 2025)

Biocryst Pharmaceuticals (BCRX) has disclosed Return on Equity for 8 consecutive years, with 0.08% as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Return on Equity fell 38.0% year-over-year to 0.08%, compared with a TTM value of 0.08% through Jun 2025, down 38.0%, and an annual FY2025 reading of 0.89%, down 108.0% over the prior year.
  • Return on Equity was 0.08% for Q2 2025 at Biocryst Pharmaceuticals, down from 0.12% in the prior quarter.
  • Across five years, Return on Equity topped out at 0.49% in Q3 2024 and bottomed at 0.03% in Q2 2023.
  • Average Return on Equity over 3 years is 0.24%, with a median of 0.19% recorded in 2023.
  • The sharpest move saw Return on Equity surged 46bps in 2024, then crashed -38bps in 2025.
  • Year by year, Return on Equity stood at 0.39% in 2023, then crashed by -52bps to 0.19% in 2024, then tumbled by -57bps to 0.08% in 2025.
  • Business Quant data shows Return on Equity for BCRX at 0.08% in Q2 2025, 0.12% in Q1 2025, and 0.19% in Q4 2024.